{"id":"autologous-dc-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Chills"}]},"_chembl":{"chemblId":"CHEMBL3931570","moleculeType":"Small molecule","molecularWeight":"307.39"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"This therapy involves the extraction of dendritic cells from the patient, which are then pulsed with tumor antigens and reinfused into the patient to enhance the immune system's ability to recognize and destroy cancer cells.","oneSentence":"Autologous dendritic cells are loaded with tumor antigens to stimulate a patient-specific immune response against cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:56:31.395Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Advanced solid tumors"}]},"trialDetails":[{"nctId":"NCT07475182","phase":"EARLY_PHASE1","title":"Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers","status":"RECRUITING","sponsor":"Hainan Cancer Hospital","startDate":"2025-12-06","conditions":"Advanced Solid Cancers","enrollment":10},{"nctId":"NCT06254326","phase":"PHASE1","title":"ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2024-09-19","conditions":"Recurrent Oligodendroglioma, Progressive Oligodendroglioma","enrollment":12},{"nctId":"NCT04335890","phase":"PHASE1","title":"IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma","status":"COMPLETED","sponsor":"Hasumi International Research Foundation","startDate":"2020-09-24","conditions":"Melanoma, Uveal Metastatic","enrollment":17},{"nctId":"NCT05261750","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-04-30","conditions":"Nasopharyngeal Cancer","enrollment":15},{"nctId":"NCT07416240","phase":"EARLY_PHASE1","title":"Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.","status":"RECRUITING","sponsor":"Hainan Cancer Hospital","startDate":"2026-02-18","conditions":"Advanced Pancreatic Cancer","enrollment":10},{"nctId":"NCT03334305","phase":"PHASE1","title":"Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-05-16","conditions":"Malignant Glioma, High Grade Glioma","enrollment":18},{"nctId":"NCT07374029","phase":"PHASE1","title":"Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML","status":"NOT_YET_RECRUITING","sponsor":"David Avigan","startDate":"2026-07","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse","enrollment":30},{"nctId":"NCT07365280","phase":"PHASE2","title":"Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"ZSky Biotech Inc","startDate":"2026-01-09","conditions":"Glioblastoma","enrollment":78},{"nctId":"NCT07329959","phase":"PHASE1","title":"CAR-DC for End-Stage IPF","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-02-01","conditions":"Idiopathic Pulmonary Fibrosis(IPF)","enrollment":8},{"nctId":"NCT07307053","phase":"PHASE1, PHASE2","title":"Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)","status":"NOT_YET_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-01-01","conditions":"Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":600},{"nctId":"NCT06514898","phase":"PHASE1","title":"Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2025-05-05","conditions":"Recurrent Group 3 Medulloblastoma, Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma","enrollment":12},{"nctId":"NCT07260058","phase":"PHASE1, PHASE2","title":"Immune Cell Therapy for Advanced Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.","startDate":"2025-12-01","conditions":"Lung Cancer (Locally Advanced or Metastatic), Liver Cancer (Locally Advanced or Metastatic), Colorectal Cancer (Locally Advanced or Metastatic)","enrollment":48},{"nctId":"NCT05631899","phase":"PHASE1","title":"CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2023-04-03","conditions":"Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V","enrollment":9},{"nctId":"NCT05773859","phase":"PHASE1, PHASE2","title":"NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2023-03-17","conditions":"Epithelial Ovarian Cancer, Ovarian Carcinoma","enrollment":10},{"nctId":"NCT00510497","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cell Vaccine in HIV1 Infection","status":"COMPLETED","sponsor":"Sharon Riddler","startDate":"2007-07","conditions":"HIV Infections","enrollment":11},{"nctId":"NCT06100705","phase":"PHASE2","title":"Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-12-20","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":26},{"nctId":"NCT03396575","phase":"PHASE1","title":"Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-07-17","conditions":"Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma","enrollment":11},{"nctId":"NCT03758625","phase":"PHASE1","title":"Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure","status":"COMPLETED","sponsor":"Sharon Riddler","startDate":"2019-01-02","conditions":"HIV Infections","enrollment":40},{"nctId":"NCT07202611","phase":"PHASE2","title":"DC/NK Cell Therapy","status":"RECRUITING","sponsor":"National Taiwan University Clinical Trial Center","startDate":"2022-12-02","conditions":"Lung Cancer (NSCLC)","enrollment":10},{"nctId":"NCT07204496","phase":"","title":"A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced Bladder Cancer","status":"NOT_YET_RECRUITING","sponsor":"Shanghai 10th People's Hospital","startDate":"2025-09-26","conditions":"Advanced Bladder Cancer","enrollment":20},{"nctId":"NCT06175221","phase":"PHASE2","title":"Autologous TLPO Vaccine Basket","status":"TERMINATED","sponsor":"Elios Therapeutics, LLC","startDate":"2023-11-29","conditions":"Tumor, Solid, Tumor Metastasis, Cancer","enrollment":63},{"nctId":"NCT04201873","phase":"PHASE1","title":"Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2020-01-08","conditions":"Recurrent Glioblastoma","enrollment":40},{"nctId":"NCT02775292","phase":"PHASE1","title":"Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2017-01-03","conditions":"Adult Solid Neoplasm, Childhood Solid Neoplasm, Metastatic Neoplasm","enrollment":1},{"nctId":"NCT04523688","phase":"PHASE2","title":"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2021-03-25","conditions":"Glioblastoma, Vaccination","enrollment":28},{"nctId":"NCT07068555","phase":"PHASE1, PHASE2","title":"Prostate Cancer Vaccines","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2025-06-15","conditions":"Prostate Cancer Indications","enrollment":30},{"nctId":"NCT05195619","phase":"PHASE1","title":"Personalized DC Vaccines in Non Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2022-03-22","conditions":"Non-small Cell Lung Cancer","enrollment":16},{"nctId":"NCT00683670","phase":"PHASE1","title":"Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-08","conditions":"Melanoma","enrollment":17},{"nctId":"NCT04157127","phase":"PHASE1","title":"Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma","status":"RECRUITING","sponsor":"Diakonos Oncology Corporation","startDate":"2020-08-03","conditions":"Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Adenosquamous Carcinoma","enrollment":18},{"nctId":"NCT06972576","phase":"PHASE1","title":"Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-09","conditions":"Non-Small Cell Lung Cancer","enrollment":18},{"nctId":"NCT05127824","phase":"PHASE2","title":"Autologous Dendritic Cell Vaccine in Kidney Cancer","status":"RECRUITING","sponsor":"Jodi Maranchie","startDate":"2023-07-06","conditions":"Carcinoma, Renal Cell","enrollment":42},{"nctId":"NCT06946615","phase":"PHASE1","title":"Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-08","conditions":"Colorectal Neoplasia","enrollment":18},{"nctId":"NCT06749925","phase":"PHASE3","title":"Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2026-01","conditions":"Glioblastoma","enrollment":186},{"nctId":"NCT04627246","phase":"PHASE1","title":"Personalized Vaccine with SOC Chemo Followed by Nivo in Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2020-09-11","conditions":"Pancreatic Adenocarcinoma","enrollment":14},{"nctId":"NCT04968366","phase":"PHASE1","title":"Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2021-07-30","conditions":"Glioblastoma Multiforme of Brain","enrollment":11},{"nctId":"NCT06522919","phase":"PHASE2","title":"Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2025-01-07","conditions":"Colorectal Cancer Metastatic, Microsatellite Stable Colorectal Carcinoma, Refractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer","enrollment":36},{"nctId":"NCT03546361","phase":"PHASE1","title":"CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2019-07-08","conditions":"Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8","enrollment":24},{"nctId":"NCT01973322","phase":"PHASE2","title":"Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized \"Proof-of-principle\" Phase II Study","status":"COMPLETED","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2013-10-08","conditions":"Malignant Melanoma of Skin Stage III, Malignant Melanoma of Skin Stage IV","enrollment":34},{"nctId":"NCT01291420","phase":"PHASE1, PHASE2","title":"Dendritic Cell Vaccination for Patients with Solid Tumors","status":"COMPLETED","sponsor":"University Hospital, Antwerp","startDate":"2010-05-03","conditions":"Glioblastoma, Renal Cell Carcinoma, Sarcomas","enrollment":48},{"nctId":"NCT03395587","phase":"PHASE2","title":"Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2018-03-06","conditions":"Glioblastoma","enrollment":136},{"nctId":"NCT02301611","phase":"PHASE2","title":"Phase IIB TL + YCWP + DC in Melanoma","status":"COMPLETED","sponsor":"Elios Therapeutics, LLC","startDate":"2015-01","conditions":"Melanoma","enrollment":187},{"nctId":"NCT05882305","phase":"EARLY_PHASE1","title":"KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial","status":"WITHDRAWN","sponsor":"Kousai Bio Co., Ltd.","startDate":"2023-06-10","conditions":"EBV-associated Lymphomas","enrollment":""},{"nctId":"NCT03546426","phase":"PHASE1","title":"Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2019-12-12","conditions":"Mesothelioma, Malignant, PD-L1 Negative, Advanced Cancer","enrollment":18},{"nctId":"NCT02649582","phase":"PHASE1, PHASE2","title":"Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2015-12","conditions":"Glioblastoma Multiforme of Brain","enrollment":20},{"nctId":"NCT04166006","phase":"PHASE2","title":"A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2019-12-12","conditions":"Head Neck Tumors, Neuroendocrine Tumors, Soft Tissue Sarcoma","enrollment":51},{"nctId":"NCT03879512","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2018-02-07","conditions":"Childhood Glioblastoma","enrollment":24},{"nctId":"NCT01204684","phase":"PHASE2","title":"Dendritic Cell Vaccine for Patients With Brain Tumors","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2010-10-08","conditions":"Glioma, Anaplastic Astrocytoma, Anaplastic Astro-oligodendroglioma","enrollment":24},{"nctId":"NCT01898663","phase":"PHASE1, PHASE2","title":"DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML","status":"RECRUITING","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2013-06","conditions":"High-risk Soft Tissue Sarcoma","enrollment":30},{"nctId":"NCT04911621","phase":"PHASE1, PHASE2","title":"Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2021-09-10","conditions":"High Grade Glioma, Diffuse Intrinsic Pontine Glioma","enrollment":10},{"nctId":"NCT02728102","phase":"PHASE2","title":"Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2016-07","conditions":"Multiple Myeloma","enrollment":203},{"nctId":"NCT03927222","phase":"PHASE2","title":"Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma","status":"TERMINATED","sponsor":"Mustafa Khasraw, MBChB, MD, FRCP, FRACP","startDate":"2019-09-30","conditions":"Glioblastoma","enrollment":6},{"nctId":"NCT04487756","phase":"PHASE1, PHASE2","title":"Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Oncológico Dr Rosell","startDate":"2021-03-17","conditions":"Extensive-stage Small Cell Lung Cancer","enrollment":20},{"nctId":"NCT01686334","phase":"PHASE2","title":"Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zwi Berneman","startDate":"2012-10","conditions":"Acute Myeloid Leukemia","enrollment":130},{"nctId":"NCT06097793","phase":"EARLY_PHASE1","title":"KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial","status":"RECRUITING","sponsor":"Kousai Bio Co., Ltd.","startDate":"2023-12-04","conditions":"Nasopharyngeal Carcinoma","enrollment":12},{"nctId":"NCT03393858","phase":"PHASE1, PHASE2","title":"Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma","status":"TERMINATED","sponsor":"Capital Medical University","startDate":"2017-12-01","conditions":"Cancer, Mesothelioma, Malignant","enrollment":10},{"nctId":"NCT03190811","phase":"PHASE1, PHASE2","title":"Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2016-09","conditions":"Neoplasms","enrollment":100},{"nctId":"NCT03671720","phase":"EARLY_PHASE1","title":"Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden","status":"WITHDRAWN","sponsor":"Capital Medical University","startDate":"2018-09-11","conditions":"Advanced Cancer, Metastatic Cancer","enrollment":""},{"nctId":"NCT03360630","phase":"PHASE1, PHASE2","title":"Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2016-11-01","conditions":"Lung Cancer, Neoplasms","enrollment":60},{"nctId":"NCT05321940","phase":"PHASE1","title":"Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias","status":"WITHDRAWN","sponsor":"Juan C. Ramos, MD","startDate":"2023-11-30","conditions":"Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia","enrollment":""},{"nctId":"NCT03735589","phase":"PHASE1, PHASE2","title":"Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2023-12-15","conditions":"Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8","enrollment":""},{"nctId":"NCT04203901","phase":"PHASE2","title":"Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma","status":"TERMINATED","sponsor":"CoImmune","startDate":"2020-07-22","conditions":"Advanced Renal Cell Carcinoma","enrollment":16},{"nctId":"NCT00082641","phase":"PHASE1, PHASE2","title":"Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2004-01-01","conditions":"Breast Cancer","enrollment":24},{"nctId":"NCT05635591","phase":"PHASE1","title":"KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2023-01-16","conditions":"EBV-associated Haematologic Neoplasms","enrollment":9},{"nctId":"NCT05631886","phase":"PHASE1","title":"Combination of CAR-DC Vaccine and ICIs in Malignant Tumors","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2023-07-04","conditions":"Solid Tumor, Adult, Lymphoma, EphA2 Overexpression","enrollment":10},{"nctId":"NCT03803397","phase":"PHASE1","title":"Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma","status":"UNKNOWN","sponsor":"PrimeVax Immuno-Oncology Inc.","startDate":"2024-04-01","conditions":"Metastatic Melanoma","enrollment":10},{"nctId":"NCT00639639","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"Gary Archer Ph.D.","startDate":"2006-02-06","conditions":"Malignant Neoplasms of Brain","enrollment":42},{"nctId":"NCT04615845","phase":"PHASE1","title":"Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC-PC)","status":"TERMINATED","sponsor":"Pharmicell Co., Ltd.","startDate":"2021-06-21","conditions":"Castration Resistant Prostate Cancer, CRPC","enrollment":3},{"nctId":"NCT04614051","phase":"PHASE1","title":"Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC)","status":"TERMINATED","sponsor":"Pharmicell Co., Ltd.","startDate":"2021-03-30","conditions":"Ovarian Cancer","enrollment":2},{"nctId":"NCT05622825","phase":"PHASE1, PHASE2","title":"Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2023-01","conditions":"Advanced Liver Cancers","enrollment":15},{"nctId":"NCT01197625","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Curative Resected Prostate Cancer Patients","status":"UNKNOWN","sponsor":"Oslo University Hospital","startDate":"2010-09","conditions":"Prostate Cancer","enrollment":30},{"nctId":"NCT05554484","phase":"PHASE1, PHASE2","title":"AMI-DC in Patients With Anterior Wall Myocardial Infarction","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2021-06-07","conditions":"Myocardial Infarction","enrollment":30},{"nctId":"NCT05461235","phase":"PHASE2","title":"Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma","status":"UNKNOWN","sponsor":"China Medical University, China","startDate":"2022-07-15","conditions":"PD-1 Antibody, DC-Cell, NK-Cell","enrollment":1},{"nctId":"NCT02808416","phase":"PHASE1","title":"Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)","status":"COMPLETED","sponsor":"Guangdong 999 Brain Hospital","startDate":"2016-03-01","conditions":"Brain Cancer, Neoplasm Metastases","enrollment":10},{"nctId":"NCT02808364","phase":"PHASE1","title":"Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)","status":"COMPLETED","sponsor":"Guangdong 999 Brain Hospital","startDate":"2016-03-01","conditions":"Glioblastoma","enrollment":10},{"nctId":"NCT02362451","phase":"PHASE2","title":"Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2015-07-10","conditions":"Prostatic Neoplasms, Prostate Cancer","enrollment":7},{"nctId":"NCT04888611","phase":"PHASE2","title":"Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2021-10-26","conditions":"Recurrent Glioblastoma","enrollment":40},{"nctId":"NCT00026624","phase":"PHASE1","title":"Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT05020119","phase":"PHASE1","title":"Neoantigen-expanded Autologous Immune Cell Therapy","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-04-09","conditions":"Advanced Solid Tumor","enrollment":9},{"nctId":"NCT05000801","phase":"NA","title":"Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2021-07-01","conditions":"Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT04999943","phase":"PHASE1","title":"Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome","status":"RECRUITING","sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","startDate":"2021-07-01","conditions":"Myelodysplastic Syndromes, Dendritic Cell, Hypomethylating Agents","enrollment":40},{"nctId":"NCT01826877","phase":"PHASE1","title":"Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2013-01-14","conditions":"Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer","enrollment":12},{"nctId":"NCT00703105","phase":"PHASE2","title":"Ovarian Dendritic Cell Vaccine Trial","status":"UNKNOWN","sponsor":"Loyola University","startDate":"2008-10","conditions":"Ovarian Cancer","enrollment":36},{"nctId":"NCT01302496","phase":"PHASE2","title":"Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma","status":"COMPLETED","sponsor":"Bart Neyns","startDate":"2011-02","conditions":"Malignant Melanoma Stage III, Malignant Melanoma Stage IV","enrollment":39},{"nctId":"NCT02851784","phase":"PHASE2, PHASE3","title":"Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Chinese PLA General Hospital","startDate":"2009-12","conditions":"Hepatocellular Carcinoma","enrollment":40},{"nctId":"NCT00961844","phase":"PHASE1, PHASE2","title":"Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma","status":"TERMINATED","sponsor":"Steinar Aamdal","startDate":"2009-08","conditions":"Metastatic Malignant Melanoma","enrollment":15},{"nctId":"NCT01334047","phase":"PHASE1, PHASE2","title":"Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients","status":"TERMINATED","sponsor":"Steinar Aamdal","startDate":"2011-04","conditions":"Recurrent Epithelial Ovarian Cancer","enrollment":5},{"nctId":"NCT04567069","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment","status":"UNKNOWN","sponsor":"The Second Hospital of Shandong University","startDate":"2020-09","conditions":"Gastric Cancer","enrollment":45},{"nctId":"NCT00601094","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2009-02-26","conditions":"Lung Cancer","enrollment":17},{"nctId":"NCT00005617","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"1997-07","conditions":"Melanoma","enrollment":""},{"nctId":"NCT00022334","phase":"PHASE1, PHASE2","title":"Vaccine Therapy in Treating Patients With Liver Cancer","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2001-01","conditions":"Liver Cancer","enrollment":33},{"nctId":"NCT00068510","phase":"PHASE1","title":"Vaccine Therapy in Treating Patients With Malignant Glioma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2003-06","conditions":"Brain and Central Nervous System Tumors","enrollment":28},{"nctId":"NCT02405338","phase":"PHASE1, PHASE2","title":"DC Vaccination for Post-remission Therapy in AML","status":"COMPLETED","sponsor":"Medigene AG","startDate":"2015-03","conditions":"Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT02529072","phase":"PHASE1","title":"Nivolumab With DC Vaccines for Recurrent Brain Tumors","status":"COMPLETED","sponsor":"Gary Archer Ph.D.","startDate":"2016-01","conditions":"Malignant Glioma, Astrocytoma, Glioblastoma","enrollment":6},{"nctId":"NCT04292769","phase":"PHASE3","title":"Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors","status":"UNKNOWN","sponsor":"Li Yu","startDate":"2020-01-21","conditions":"Malignant Neoplasm","enrollment":200},{"nctId":"NCT01239875","phase":"EARLY_PHASE1","title":"Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-11","conditions":"Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma","enrollment":16},{"nctId":"NCT03119025","phase":"PHASE1, PHASE2","title":"Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection","status":"COMPLETED","sponsor":"Russian Academy of Medical Sciences","startDate":"2015-05","conditions":"Hepatitis C, Chronic, Liver Diseases, Hepatitis","enrollment":10},{"nctId":"NCT01875653","phase":"PHASE3","title":"Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma","status":"TERMINATED","sponsor":"Lisata Therapeutics, Inc.","startDate":"2014-10","conditions":"Stage IV Melanoma, Stage III Melanoma","enrollment":4},{"nctId":"NCT03871205","phase":"PHASE1","title":"Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer","status":"UNKNOWN","sponsor":"Shenzhen People's Hospital","startDate":"2019-04-01","conditions":"Carcinoma, Non-Small Cell Lung, Carcinoma, Small Cell Lung","enrollment":30},{"nctId":"NCT02070406","phase":"PHASE1","title":"Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies","status":"TERMINATED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2014-07-17","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":4},{"nctId":"NCT03226236","phase":"PHASE2","title":"Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC","status":"WITHDRAWN","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2016-03","conditions":"Carcinoma, Renal Cell, Vaccination, Secondary","enrollment":""},{"nctId":"NCT00038870","phase":"NA","title":"Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2001-01-31","conditions":"Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":41,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"Autologous DC Therapy","genericName":"Autologous DC Therapy","companyName":"Diakonos Oncology Corporation","companyId":"diakonos-oncology-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"Autologous dendritic cells are loaded with tumor antigens to stimulate a patient-specific immune response against cancer cells. Used for Advanced solid tumors.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}